Yung-Jue Bang - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Yung-Jue Bang

This paper is made freely available by the publisher.

2024 Nick Pavlakis

ORCID

, Kohei Shitara

ORCID

, Katrin Sjoquist

ORCID

, Andrew Martin, Anthony Jaworski, Niall Tebbutt

ORCID

, Yung-Jue Bang

ORCID

, Thierry Alcindor

ORCID

, Chris O'Callaghan, Andrew Strickland, Sun Young Rha

ORCID

, Keun-Wook Lee

ORCID

ORCID

ORCID

ORCID

and 6 other authors

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Vivek Subbiah

ORCID

, Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen

ORCID

, Alexander Stein, Patrick Y. Wen, Sascha Dietrich, Maja J. A. de Jonge, Jean-Yves Blay

ORCID

, Antoine Italiano

ORCID

, Kan Yonemori, Daniel C. Cho, Filip Y. F. L. de Vos

ORCID

, Philippe Moreau and 8 other authors

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Upload

This paper is made freely available by the publisher.

2022 Tae Won Kim

ORCID

, Howard A. Burris, Maria J. de Miguel Luken

ORCID

, Michael J. Pishvaian

ORCID

, Yung-Jue Bang

ORCID

, Michael Gordon

ORCID

ORCID

, D. Ross Camidge, F. Stephen Hodi, Grant A. McArthur

ORCID

, Wilson H. Miller, Andres Cervantes

ORCID

, Laura Q. Chow

ORCID

, Alexander M. Lesokhin

ORCID

, Annemie Rutten and 10 other authors

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors

Download from aacrjournals.org

This paper is made freely available by the publisher.

Sehhoon Park

ORCID

, Chan-Young Ock

ORCID

ORCID

, Sergio Pereira, Seonwook Park

ORCID

, Minuk Ma

ORCID

, Sangjoon Choi

ORCID

ORCID

, Seunghwan Shin

ORCID

, Brian Jaehong Aum

ORCID

, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha

ORCID

, Sunyoung Park, Koung Jin Suh and 14 other authors

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Keun-Wook Lee

ORCID

, Eric Van Cutsem, Yung-Jue Bang

ORCID

, Charles S. Fuchs, Iveta Kudaba, Marcelo Garrido

ORCID

, Hyun Cheol Chung

ORCID

, Jeeyun Lee, Hugo R. Castro, Joseph Chao

ORCID

, Zev A. Wainberg, Z. Alexander Cao, Deepti Aurora-Garg, Julie Kobie, Razvan Cristescu

ORCID

and 5 other authors

Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 Antoine Hollebecque

ORCID

, Hyun C. Chung, Maria J. de Miguel

ORCID

, Antoine Italiano, Jean-Pascal Machiels, Chia-Chi Lin

ORCID

, Neesha C. Dhani, Marc Peeters

ORCID

, Victor Moreno

ORCID

, Wu-Chou Su, Kay Hoong Chow, Violeta R. Galvao, Michelle Carlsen, Danni Yu, Anna M. Szpurka

ORCID

and 5 other authors

Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors

Upload

This paper is made freely available by the publisher.

Shunji Takahashi, Masato Karayama

ORCID

, Masato Takahashi

ORCID

, Junichiro Watanabe

ORCID

, Hironobu Minami

ORCID

, Noboru Yamamoto

ORCID

, Ichiro Kinoshita, Chia-Chi Lin

ORCID

, Young-Hyuck Im, Issei Achiwa, Emi Kamiyama, Yasuyuki Okuda, Caleb Lee

ORCID

, Yung-Jue Bang

ORCID

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors

Download from aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

James J. Harding, Victor Moreno

ORCID

, Yung-Jue Bang

ORCID

ORCID

, Amita Patnaik, José Trigo

ORCID

, Anna M. Szpurka

ORCID

, Noboru Yamamoto

ORCID

, Toshihiko Doi

ORCID

, Siqing Fu, Boris Calderon

ORCID

, Nieves Velez de Mendizabal, Emiliano Calvo

ORCID

, Danni Yu, Leena Gandhi and 4 other authors

Blocking TIM-3 in Treatment-Refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody

Upload

This paper was not found in any repository, but could be made available legally by the author.

Zev A. Wainberg, Charles S. Fuchs, Josep Tabernero

ORCID

, Kohei Shitara, Kei Muro, Eric Van Cutsem, Yung-Jue Bang

ORCID

, Hyun Cheol Chung, Kensei Yamaguchi

ORCID

, Eniko Varga, Jen-Shi Chen

ORCID

, Daniel Hochhauser, Peter Thuss-Patience, Salah-Eddin Al-Batran, Marcelo Garrido

ORCID

and 5 other authors

Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Amita Patnaik, Timothy A. Yap

ORCID

, Hyun Cheol Chung, Maria J. de Miguel

ORCID

, Yung-Jue Bang

ORCID

ORCID

, Wu-Chou Su, Antoine Italiano, Kay Hoong Chow, Anna M. Szpurka, Danni Yu, Yumin Zhao, Michelle Carlsen, Shelly Schmidt, Burkhard Vangerow and 3 other authors

Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: the PACT phase Ia/Ib trial

Upload

This paper is made freely available by the publisher.

Markus Moehler

ORCID

, Mikhail Dvorkin, Narikazu Boku

ORCID

, Mustafa Özgüroğlu

ORCID

, Min-Hee Ryu, Alina S. Muntean, Sara Lonardi

ORCID

, Antonio Cubillo Gracian, Toshimi Takano

ORCID

, Marina Nechaeva, Rachel Wong

ORCID

, Arinilda C. Bragagnoli, Howard Safran, Gina M. Vaccaro, Hasan S. Coşkun and 6 other authors

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Yung-Jue Bang

ORCID

, Talia Golan, Laetitia Dahan, Siqing Fu, Victor Moreno

ORCID

, Keunchil Park, Ravit Geva, Filippo De Braud, Zev A. Wainberg, Martin Reck, Laura Goff

ORCID

, Naomi Laing, Gu Mi

ORCID

, Joana M. Oliveira, Heather Wasserstrom and 1 other authors

Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

Upload

This paper is made freely available by the publisher.

2019 Yung‐Jue Bang

ORCID

, Wu‐Chou Su, Martin Schuler, Do‐Hyun Nam, Wan Teck Lim, Todd M. Bauer

ORCID

, Analia Azaro, Ronnie Tung Ping Poon, David Hong, Chia‐Chi Lin

ORCID

, Mikhail Akimov, Samson Ghebremariam, Sylvia Zhao, Monica Giovannini, Brigette Ma

Phase 1 study of capmatinib in MET‐positive solid tumor patients: Dose escalation and expansion of selected cohorts

Download from doi.org

Missing publications? Search for publications with a matching author name.